As aging progresses, the quality of DNA and proteins inside cells declines, which is known to be the cause of various ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of "genetic surgery" is performed on DNA, for ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Xenium Protein, a ...

Merck KGaA has swooped into a neurological-focused pact with RNA biotech Skyhawk Therapeutics that could top out at $2 ...

In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double ...

Researchers at San Diego State University and Michigan State University are shedding new light on how viruses meticulously ...

Using artificial intelligence, MIT researchers have come up with a new way to design nanoparticles that can more efficiently ...

New research published in Nature has uncovered powerful evidence that may explain why a new chemical modification of RNA is ...

Rapid precision run-on sequencing (rPRO-seq) may help doctors understand disease states and treatment response in real time.

A previously unknown virus in farmed Pacific oysters may hold the key to mass die-offs in the multimillion-dollar industry, ...

Researchers identified messenger RNA that is missing in pediatric high-grade glioma tumors but not in normal brain tissues.

We recently published 10 Stocks With Easy 15-30% Upside. Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the best-performing ...